Marks Group Wealth Management’s Rentokil RTO Stock Holding History

Marks Group Wealth Management’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-18,122	Closed	-$452K	–	298
2024 Q3	$452K	Sell	18,122 -4,066	-18%	-$120K	0.04%	229
2024 Q2	$658K	Buy	22,188 +895	+4%	+$24.8K	0.07%	199
2024 Q1	$642K	Buy	21,293 +2,107	+11%	+$58.5K	0.07%	203
2023 Q4	$549K	Buy	19,186 +272	+1%	+$7.99K	0.06%	211
2023 Q3	$701K	Sell	18,914 -117	-0.6%	-$4.47K	0.09%	184
2023 Q2	$742K	Buy	19,031 +127	+0.7%	+$4.98K	0.09%	183
2023 Q1	$690K	Buy	18,904 +51	+0.3%	+$1.61K	0.09%	184
2022 Q4	$581K	Buy	+18,853	New	+$585K	0.08%	197

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Marks Group Wealth Management's RTO Position: Q4 2024 in Review

Marks Group Wealth Management sold out of Rentokil (RTO) in Q4 2024, closing a stake of 18,122 shares — an estimated $452K sold.

Marks Group Wealth Management first reported a position in RTO in Q4 2022 and held it in 8 quarters. The position peaked at $742K in Q2 2023. 226 funds tracked by Wall St. Rank hold RTO as of Q4 2024.

Marks Group Wealth Management reported no remaining Rentokil position as of Q4 2024 after selling out during the quarter.
Marks Group Wealth Management sold 18,122 Rentokil shares in Q4 2024, an estimated $452K.
Marks Group Wealth Management first reported a position in Rentokil in Q4 2022 and held it in 8 quarters.
Marks Group Wealth Management's Rentokil position peaked at $742K in Q2 2023.
226 funds tracked by Wall St. Rank held Rentokil as of Q4 2024.

Based on Marks Group Wealth Management's 13F filing for Q4 2024, filed 29 Jan 2025.